Press Release

Go to Topics

Back number


Advanced Medical Care Approval for Cancer Gene Panel Testing at the Time of Initial Treatment
- Prospective Study to Assess the Feasibility and Clinical Utility of Comprehensive Genomic Profiling at the Time of Initial Treatment of Patients with Solid Tumors - (PDF:122KB)
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
- Aiming for early introduction of test kits for in vitro diagnostic medical devices in medical institutions - (PDF:183KB)
Announcement of Organizational and Personnel Changes (PDF:376KB)
Sysmex to Introduce New Globally Consistent Job-Based HR Management System with the Aim of Realizing Sustainable Growth
Sysmex and the Kobe City Eye Hospital Sign a Comprehensive Collaboration Agreement
-Reinforcing Collaboration toward the Realization of Genomic Medicine in the Area of Ophthalmic Disorders- (PDF:120KB)
Sysmex Presents Academic Report Related to the Clinical Utility of RAS Gene Mutation Testing for Colorectal Cancer Using Liquid Biopsy
Details of Report on Clinical Utility of OncoBEAM™ RAS CRC Kit presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 2020 (ASCO-GI 2020) (PDF:130KB)
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2020 (PDF:506KB)
Sysmex and RIKEN Innovation Sign a Comprehensive Collaborative Agreement
Sysmex Invests in Astrego Diagnostics with a View to Developing New Urinalysis Solutions for the Primary Care Business
Sysmex Receives Regulatory Approval in China of an in Vitro Diagnostic Reagent to Help Diagnose Breast Cancer Lymph Node Metastasis Using the OSNA™ Method
-Aiming to Introduce a System to Test for Breast Cancer Lymph Node Metastasis into the Chinese Market-
Sysmex Launches Gene Testing Kit for Blood Cancer (ipsogen JAK2 DX Reagent)
First Insurance Coverage in Japan for JAK2V617F Gene Mutation Testing for Myeloproliferative Neoplasms